248 related articles for article (PubMed ID: 19603082)
1. Lipopolysaccharide-squamous cell carcinoma-monocyte interactions induce cancer-supporting factors leading to rapid STAT3 activation.
Kurago ZB; Lam-ubol A; Stetsenko A; De La Mater C; Chen Y; Dawson DV
Head Neck Pathol; 2008 Mar; 2(1):1-12. PubMed ID: 19603082
[TBL] [Abstract][Full Text] [Related]
2. Chemerin promotes invasion of oral squamous cell carcinoma by stimulating IL-6 and TNF-α production via STAT3 activation.
Lu Z; Liu J; Wan Q; Wu Y; Wu W; Chen Y
Mol Biol Rep; 2024 Mar; 51(1):436. PubMed ID: 38520551
[TBL] [Abstract][Full Text] [Related]
3. STAT3 signal transduction through interleukin-22 in oral squamous cell carcinoma.
Naher L; Kiyoshima T; Kobayashi I; Wada H; Nagata K; Fujiwara H; Ookuma YF; Ozeki S; Nakamura S; Sakai H
Int J Oncol; 2012 Nov; 41(5):1577-86. PubMed ID: 22922995
[TBL] [Abstract][Full Text] [Related]
4. Human autologous monocytes and monocyte-derived macrophages in co-culture with carcinoma F-spheroids secrete IL-6 by a non-CD14-dependent pathway.
Heimdal JH; Aarstad HJ; Olsnes C; Olofsson J
Scand J Immunol; 2001 Feb; 53(2):162-70. PubMed ID: 11169220
[TBL] [Abstract][Full Text] [Related]
5. 14-3-3ζ regulates immune response through Stat3 signaling in oral squamous cell carcinoma.
Han X; Han Y; Jiao H; Jie Y
Mol Cells; 2015; 38(2):112-21. PubMed ID: 25556369
[TBL] [Abstract][Full Text] [Related]
6. Monocyte and monocyte-derived macrophage secretion of MCP-1 in co-culture with autologous malignant and benign control fragment spheroids.
Heimdal JH; Olsnes C; Olofsson J; Aarstad HJ
Cancer Immunol Immunother; 2001 Aug; 50(6):300-6. PubMed ID: 11570583
[TBL] [Abstract][Full Text] [Related]
7. Humanized anti-interleukin-6 receptor antibody suppresses tumor angiogenesis and in vivo growth of human oral squamous cell carcinoma.
Shinriki S; Jono H; Ota K; Ueda M; Kudo M; Ota T; Oike Y; Endo M; Ibusuki M; Hiraki A; Nakayama H; Yoshitake Y; Shinohara M; Ando Y
Clin Cancer Res; 2009 Sep; 15(17):5426-34. PubMed ID: 19706815
[TBL] [Abstract][Full Text] [Related]
8. Squamous carcinoma cells influence monocyte phenotype and suppress lipopolysaccharide-induced TNF-alpha in monocytes.
Lam-ubol A; Hopkin D; Letuchy EM; Kurago ZB
Inflammation; 2010 Aug; 33(4):207-23. PubMed ID: 20084448
[TBL] [Abstract][Full Text] [Related]
9. Characterization of STAT3 expression, signaling and inhibition in feline oral squamous cell carcinoma.
Brown ME; Bear MD; Rosol TJ; Premanandan C; Kisseberth WC; London CA
BMC Vet Res; 2015 Aug; 11():206. PubMed ID: 26272737
[TBL] [Abstract][Full Text] [Related]
10. Tumor microenvironment and Oral Squamous Cell Carcinoma: A crosstalk between the inflammatory state and tumor cell migration.
Alves A; Diel L; Ramos G; Pinto A; Bernardi L; Yates J; Lamers M
Oral Oncol; 2021 Jan; 112():105038. PubMed ID: 33129055
[TBL] [Abstract][Full Text] [Related]
11. Oct4 downregulation-induced inflammation increases the migration and invasion rate of oral squamous cell carcinoma.
Sun S; Yang H; Wang F; Zhao S
Acta Biochim Biophys Sin (Shanghai); 2021 Nov; 53(11):1440-1449. PubMed ID: 34553218
[TBL] [Abstract][Full Text] [Related]
12. Clinical Roles of Interleukin-6 and STAT3 in Oral Squamous Cell Carcinoma.
Shinagawa K; Yanamoto S; Naruse T; Kawakita A; Morishita K; Sakamoto Y; Rokutanda S; Umeda M
Pathol Oncol Res; 2017 Apr; 23(2):425-431. PubMed ID: 27744625
[TBL] [Abstract][Full Text] [Related]
13. Interleukin 6 and interleukin 8 as potential biomarkers for oral cavity and oropharyngeal squamous cell carcinoma.
St John MA; Li Y; Zhou X; Denny P; Ho CM; Montemagno C; Shi W; Qi F; Wu B; Sinha U; Jordan R; Wolinsky L; Park NH; Liu H; Abemayor E; Wong DT
Arch Otolaryngol Head Neck Surg; 2004 Aug; 130(8):929-35. PubMed ID: 15313862
[TBL] [Abstract][Full Text] [Related]
14. Loss of IL-6 receptor expression in cervical carcinoma cells inhibits autocrine IL-6 stimulation: abrogation of constitutive monocyte chemoattractant protein-1 production.
Hess S; Smola H; Sandaradura De Silva U; Hadaschik D; Kube D; Baldus SE; Flucke U; Pfister H
J Immunol; 2000 Aug; 165(4):1939-48. PubMed ID: 10925276
[TBL] [Abstract][Full Text] [Related]
15. 2-O-Methylmagnolol Induces Apoptosis and Inhibits IL-6/STAT3 Signaling in Oral Squamous Cell Carcinoma.
Wang TH; Fang JY; Wu SJ; Liu YW; Chan CW; Chuang SY; Chen CY
Cell Physiol Biochem; 2018; 50(3):883-892. PubMed ID: 30355952
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-6 mediated inflammasome activation promotes oral squamous cell carcinoma progression via JAK2/STAT3/Sox4/NLRP3 signaling pathway.
Xiao L; Li X; Cao P; Fei W; Zhou H; Tang N; Liu Y
J Exp Clin Cancer Res; 2022 May; 41(1):166. PubMed ID: 35513871
[TBL] [Abstract][Full Text] [Related]
17. M1-like tumor-associated macrophages cascade a mesenchymal/stem-like phenotype of oral squamous cell carcinoma via the IL6/Stat3/THBS1 feedback loop.
You Y; Tian Z; Du Z; Wu K; Xu G; Dai M; Wang Y; Xiao M
J Exp Clin Cancer Res; 2022 Jan; 41(1):10. PubMed ID: 34991668
[TBL] [Abstract][Full Text] [Related]
18. Roles of VEGF-Flt-1 signaling in malignant behaviors of oral squamous cell carcinoma.
Subarnbhesaj A; Miyauchi M; Chanbora C; Mikuriya A; Nguyen PT; Furusho H; Ayuningtyas NF; Fujita M; Toratani S; Takechi M; Niida S; Takata T
PLoS One; 2017; 12(11):e0187092. PubMed ID: 29149180
[TBL] [Abstract][Full Text] [Related]
19. Epiregulin reprograms cancer-associated fibroblasts and facilitates oral squamous cell carcinoma invasion via JAK2-STAT3 pathway.
Wang Y; Jing Y; Ding L; Zhang X; Song Y; Chen S; Zhao X; Huang X; Pu Y; Wang Z; Ni Y; Hu Q
J Exp Clin Cancer Res; 2019 Jun; 38(1):274. PubMed ID: 31234944
[TBL] [Abstract][Full Text] [Related]
20. Hypertension and increased endothelial mechanical stretch promote monocyte differentiation and activation: roles of STAT3, interleukin 6 and hydrogen peroxide.
Loperena R; Van Beusecum JP; Itani HA; Engel N; Laroumanie F; Xiao L; Elijovich F; Laffer CL; Gnecco JS; Noonan J; Maffia P; Jasiewicz-Honkisz B; Czesnikiewicz-Guzik M; Mikolajczyk T; Sliwa T; Dikalov S; Weyand CM; Guzik TJ; Harrison DG
Cardiovasc Res; 2018 Sep; 114(11):1547-1563. PubMed ID: 29800237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
